Amendment No. 1 with regard to Securities Purchase AgreementSecurities Purchase Agreement • December 7th, 2023 • Qualigen Therapeutics, Inc. • Pharmaceutical preparations
This Amendment No. 1 (“Amendment”) is made between the undersigned parties to that certain Securities Purchase Agreement between them dated December 21, 2022 (the “SPA”). All capitalized terms used but not defined herein shall have the meanings ascribed to them in the SPA or in the outstanding Debenture or the outstanding Warrant (each as issued pursuant to the SPA).
